XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2021
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s condensed consolidated statements of operation for each of the three and nine months ended December 31, 2021 and 2020:

 

 

 

For the Three Months Ended December 31,

 

 

For the Nine Months Ended December 31,

 

 

 

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

 

 

(in thousands)

 

Cost of revenue

 

$

1,259

 

 

$

1,061

 

 

$

3,589

 

 

$

2,689

 

Research and development

 

 

2,278

 

 

 

1,922

 

 

 

6,681

 

 

 

5,069

 

Selling, general and administrative

 

 

8,846

 

 

 

9,873

 

 

 

30,470

 

 

 

25,961

 

 

 

$

12,383

 

 

$

12,856

 

 

$

40,740

 

 

$

33,719

 

Summary of Stock Option Activity

The following table summarizes the stock option activity for the nine months ended December 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

(in thousands)

 

 

Price

 

 

Term (years)

 

 

(in thousands)

 

Outstanding at beginning of period

 

 

711

 

 

$

141.87

 

 

5.46

 

 

 

 

 

Granted

 

 

66

 

 

 

289.01

 

 

 

 

 

 

 

 

 

Exercised

 

 

(155

)

 

 

56.98

 

 

 

 

 

 

 

 

 

Cancelled and expired

 

 

(14

)

 

 

314.28

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

608

 

 

$

175.36

 

 

 

5.72

 

 

 

113,080

 

Exercisable at end of period

 

 

462

 

 

$

147.90

 

 

4.81

 

 

 

99,031

 

Options vested and expected to vest at end of period

 

 

608

 

 

$

175.36

 

 

 

5.72

 

 

 

113,080

 

 

Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted

The weighted average grant-date fair values and weighted average assumptions used in the calculation of fair value of options granted was as follows: 

 

 

 

For the Three Months Ended December 31,

 

 

For the Nine Months Ended December 31,

 

 

 

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

Weighted average grant-date fair value

 

$

127.20

 

 

$

94.64

 

 

$

104.93

 

 

$

76.79

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Valuation assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

1.14

%

 

 

0.39

%

 

 

0.81

%

 

 

0.31

%

Expected option life (years)

 

 

5.57

 

 

 

4.17

 

 

 

4.28

 

 

 

4.22

 

Expected volatility

 

 

41.19

%

 

 

43.70

%

 

 

44.11

%

 

 

42.85

%

Restricted Stock Units  
Summary of Restricted Stock Units Activity

 

The following table summarizes activity of restricted stock units for the nine months ended December 31, 2021:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

 

 

(in thousands)

 

 

(per share)

 

Restricted stock units at beginning of period

 

 

301

 

 

$

273.57

 

Granted (1)

 

 

171

 

 

 

289.73

 

Vested

 

 

(132

)

 

 

297.00

 

Forfeited

 

 

(30

)

 

 

275.27

 

Restricted stock units at end of period

 

 

310

 

 

$

274.15

 

 

 

(1)

Includes 10 thousand performance-based awards granted due to greater than 100% target vesting.

 

Summary of Assumptions Used To Value Awards And Estimated Grant-Date Fair Value

The table below sets forth the assumptions used to value the awards and the estimated grant-date fair value:

 

 

 

May 2021

 

 

May 2020

 

Risk-free interest rate

 

 

0.3

%

 

 

0.2

%

Expected volatility

 

 

44.8

%

 

 

35.5

%

Dividend yield

 

 

 

 

 

 

Remaining performance period (years)

 

 

2.8

 

 

1.9 - 2.9

 

Estimated fair value per share

 

$

292.40

 

 

$347.05 - $349.28

 

Target performance (number of shares)

 

 

25,172

 

 

 

30,881